![Eric Lohrer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Lohrer
Direttore/Membro del Consiglio presso Amazentis SA
Posizioni attive di Eric Lohrer
Società | Posizione | Inizio | Fine |
---|---|---|---|
Helvetica Capital AG
![]() Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | Investitore di Private Equity | - | - |
Amazentis SA
![]() Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | Direttore/Membro del Consiglio | 01/11/2015 | - |
Storia della carriera di Eric Lohrer
Statistiche
Distribuzione geografica
Svizzera | 3 |
Posizioni
Private Equity Investor | 1 |
Director/Board Member | 1 |
Settori
Finance | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Helvetica Capital AG
![]() Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | Finance |
Amazentis SA
![]() Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | Commercial Services |
- Borsa valori
- Insiders
- Eric Lohrer
- Esperienza